Gálos G
Municipal St. István Hospital-Outpatient Clinic, Budapest.
Ther Hung. 1992;40(2):69-71.
Two therapeutic methods were compared on locomotor disease patients; the currently used anti-inflammatory complex therapy and the same therapy complemented with Mydocalm. On the basis of the changes of pain indices and motion indices chosen as parameters it could be concluded that Mydocalm is a valuable adjuvant, especially in improving locomotor functions, and it promotes the improvement of the general condition of the patients and the performance of their daily activities by relieving muscular hypertonia and contractures.
对运动疾病患者比较了两种治疗方法；目前使用的抗炎综合疗法以及补充了美多芭的相同疗法。根据所选作为参数的疼痛指标和运动指标的变化，可以得出结论，美多芭是一种有价值的辅助药物，特别是在改善运动功能方面，它通过缓解肌肉张力亢进和挛缩，促进患者总体状况的改善以及日常活动的进行。
